Predictors of 90-day outcome in patients stabilized after acute coronary syndromes

被引:38
作者
Newby, LK
Bhapkar, MV
White, HD
Topol, EJ
Dougherty, FC
Harrington, RA
Smith, MC
Asarch, LF
Califf, RM
机构
[1] Duke Clin Res Inst, Durham, NC 27715 USA
[2] Green Lane Hosp, Auckland 3, New Zealand
[3] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[4] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland
关键词
acute coronary syndromes; risk models; outcomes; risk stratification;
D O I
10.1016/S0195-668X(02)00325-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims We investigated predictors of 90-day risk among patients surviving the early period after an acute coronary syndrome (ACS). Methods and Results The study population included 15 904 stabilized ST-segment elevation or non-ST-segment elevation ACS patients randomized in SYMPHONY and 2nd SYMPHONY. We developed risk models for death, death or myocardial infarction (MI), and death, MI, or severe recurrent ischaemia (SRI) using Cox proportional-hazards techniques. Demographic, history, and pre-randomization clinical and medication variables were tested. Validation techniques included development of individual trial models, backward elimination and bootstrapping. Of 118 variables, 17 independently predicted mortality. The strongest associations included greater age (chi(2) = 31.1), higher randomization heart rate (chi(2) = 27.4), and heart failure (HF) variables (HF between qualifying event and randomization, chi(2) = 21.8; history of HF, chi(2) = 12.2). Higher creatinine clearance (chi(2) = 17.7) and percutaneous coronary intervention between qualifying event and randomization (chi(2) = 11.1) most strongly predicted lower risk. Similar characteristics entered the double and triple composite models, but HF variables and age less strongly predicted these end-points. Conclusions In patients stabilized after ACS, those at highest risk over the next 90 days can be identified. Typical clinical markers are better at identifying risk of death than non-fatal MI or SRI. Novel risk markers are needed for these outcomes. (C) 2003 The European Society of Cardiology. Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:172 / 181
页数:10
相关论文
共 29 条
[1]   Recurrent ischemia during continuous 12-lead ECG-ischemia monitoring in patients with acute coronary syndromes treated with eptifibatide: Relation with death and myocardial infarction [J].
Akkerhuis, KM ;
Maas, ACP ;
Klootwijk, PAJ ;
Krucoff, MW ;
Meij, S ;
Califf, RM ;
Simoons, ML .
JOURNAL OF ELECTROCARDIOLOGY, 2000, 33 (02) :127-136
[2]  
Al Suwaidi JM, 2000, CIRCULATION, V102, P792
[3]   Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction - A Thrombolysis in Myocardial Infarction 10 substudy [J].
Barron, HV ;
Cannon, CP ;
Murphy, SA ;
Braunwald, E ;
Gibson, CM .
CIRCULATION, 2000, 102 (19) :2329-2334
[4]  
Bhatt DL, 2000, CIRCULATION, V102, P776
[5]   Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability [J].
Biasucci, LM ;
Liuzzo, G ;
Grillo, RL ;
Caligiuri, G ;
Rebuzzi, AG ;
Buffon, A ;
Summaria, F ;
Ginnetti, F ;
Fadda, G ;
Maseri, A .
CIRCULATION, 1999, 99 (07) :855-860
[6]   Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation results from an international trial of 9461 patients [J].
Boersma, E ;
Pieper, KS ;
Steyerberg, EW ;
Wilcox, RG ;
Chang, WC ;
Lee, KL ;
Akkerhuis, KM ;
Harrington, RA ;
Deckers, JW ;
Armstrong, PW ;
Lincoff, AM ;
Califf, RM ;
Topol, EJ ;
Simoons, ML .
CIRCULATION, 2000, 101 (22) :2557-2567
[7]   Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. [J].
Cannon, CP ;
Weintraub, WS ;
Demopoulos, LA ;
Vicari, R ;
Frey, MJ ;
Lakkis, N ;
Neumann, FJ ;
Robertson, DH ;
DeLucca, PT ;
DiBattiste, PM ;
Gibson, CM ;
Braunwald, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (25) :1879-1887
[8]   Independent prognostic value of C-reactive protein and troponin I in patients with unstable angina or non-Q-wave myocardial infarction [J].
de Winter, RJ ;
Bholasingh, R ;
Lijmer, JG ;
Koster, RW ;
Gorgels, JPMC ;
Schouten, Y ;
Hoek, FJ ;
Sanders, GT .
CARDIOVASCULAR RESEARCH, 1999, 42 (01) :240-245
[9]   Predicting one-year mortality among elderly survivors of hospitalization for an acute myocardial infarction: Results from the Cooperative Cardiovascular Project [J].
Krumholz, HM ;
Chen, J ;
Chen, YT ;
Wang, YF ;
Radford, MJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (02) :453-459
[10]  
LANGER A, 1995, CAN J CARDIOL, V11, P117